-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/asthma-treatment_disposition-comments.pdf
September 10, 2012 - Thomas, 2009, in which the follow up was 6 months rather
than 4 weeks as stated), and in the numbers … the table emphasized the
4-week results over the 26-week since more results
were only reported at 4 weeks … His article suggests
that his main outcomes were reported at 26 weeks,
however, so we modified the … Results after
applying Buteyko techniques for 12 weeks • Reliever usage –
median reduction of 86% • … Results after applying Buteyko techniques for 12 weeks
• Reliever usage – median reduction of 86%
•
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/chronic-cough_research-protocol.pdf
October 22, 2012 - Cough that lasts more than 4 weeks in children younger than 14 years of age or more
than 8 weeks in … in
children younger than 14 years of age or more than 8 weeks in adolescents and adults
14 years … in children younger than 14 years of age or more than 8
weeks in adolescents and adults 14 years of … in
children younger than 14 years of age or more than 8 weeks in adolescents and adults 14
years of … if <14 years of age or 8 weeks if ≥14
years of age, or as stated by study authors)
o Patients with
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/episodic-migraine-surveillance-report-2.pdf
June 01, 2022 - therapy for outcomes related to pain,
function, pain relief satisfaction, and quality of life up to 4 weeks … ; 2 weeks to 4 weeks? … ; 2 weeks to 4 weeks? … ; 2 weeks to 4 weeks? … ; 2
weeks to 4 weeks
None
Settings ED, physician’s office, hospital None
Study design Original
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/gestational-diabetes-screening-diagnosis_executive.pdf
October 01, 2012 - (a)After 24 weeks’ gestation? (b) During the first trimester
and up to 24 weeks’ gestation? … at 24–28 weeks; another screened a group of participants
after 37 weeks; one study screened before … 24 weeks;
another screened women at risk between 14 and
16 weeks, with normal women screened at the … usual
24–28 weeks; and one study screened between 16 and
20 weeks or between 17 and 21 weeks followed … , and
another study screened women at high risk at 18–20 weeks
and others at 28–30 weeks.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/disruptive-behavior-disorders-research-executive-summ.pdf
April 01, 2025 - mindfulness-based
interventions) and for longer-term treatment effects in general (e.g., greater than
24 or 48 weeks … treatment as usual
+ = low strength of evidence; ++ = moderate strength of evidence
a Short term: ≤24 weeks … ; intermediate term: 25-47 weeks; long term: ≥48 weeks
In trials of pharmacotherapy, stimulants and
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/version-3-immunity-after-COVID-19-appendix-table-B-1.xlsx
January 24, 2022 - and Detroit areas with history of PcR+ and who were tested for IgG Abs to anti-S protein at least 2 weeks … responders ≥18 yrs old with history of PCR+ who were tested for IgG Abs to anti-S protein at least 2 weeks … after symptom onset If during the previous 2 weeks before survey completion they reported new onset … : 24 (3.2)*
RBD IgG ELISA Zydus diagnostics, India Time from infection
0-7 days
10-28 days
6 to 10 weeks … ;
Antibody testing every 4 weeks;
Questionnaires re symptoms and exposures every 2 weeks.
-
effectivehealthcare.ahrq.gov/sites/default/files/s89.pdf
October 01, 2007 - windows to vaccinated time windows using
hierarchical rules as follows: age within 2 years; week within
8 weeks … Williams & Wilkins S91
RESULTS
Patterns of Vaccine Exposure and Preventive
Visit Use
After 106 weeks … case of facial paralysis occurred
in the control group, reducing the LLR to 0.52, and in
subsequent weeks … As
more weeks elapsed, no additional cases occurred, and the
number of expected cases increased, causing
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/insomnia_disposition-comments.pdf
December 30, 2015 - specified duration of four weeks; that trial’s duration
was 14 days. … These were largely
excluded because study duration was less than four
weeks. … Note, page 33, line 8,
‘Eligible drug trials rarely lasted longer than 6 weeks.’ … Therefore, the target of trials of at least 4 weeks
duration seems inappropriate. … These were largely
excluded because study duration was less than four
weeks.
-
effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/mmm-draft-protocol-amendment.pdf
February 02, 2022 - individual from
complications related to pregnancy or childbirth that occur during pregnancy or within 6 weeks … following phases: immediate postpartum
(first 24 hours after delivery), early postpartum (up to 6 weeks … Mental health
coverage
● Access to substance
use disorder care
● Medicaid coverage –
up to 6 weeks … G., Weeks, L. D., & McLemore, M. R. (2020). … Pregnancy/birthing is defined as a
sustained pregnancy through at least 20
weeks gestation.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/mat-retention-strategies-rapid-review-1.pdf
August 01, 2020 - This study reported a significant association between treatment site and
retention at 20 weeks (p=0.05 … Weeks
retained:
Number of
weeks
between
induction and
the last day
the participant
was assessed … Initial value $12, maximum
$174, $30 bonus for 3
weeks of adherence,
earnings were exchanged
for … Buprenorphine
injections (weekly during
weeks 1 – 11, monthly
during weeks 12 – 24) +
daily SL placebo … vs
Placebo injections
(weekly during weeks 1 –
11, monthly during
weeks 12 – 24) + daily
SL
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/traumatic-brain-injury-rehabilitation-surveillance-160902.pdf
May 29, 2025 - $
•$ Inpatient$cognitive$rehab$
o$ Inpatient,$6$weeks$(hours/week$not$reported)$
•$ Comprehensive … $neurorehabilitation$
o$ Inpatient,$37.5$hours/week$for$6$weeks$
We$identified$no$studies$meeting … $mix$(balanced,$
interpersonal,$and$cognitive)$
o$ Outpatient$rehab$center,$5$
hours/week$for$4$weeks … $
•$ Inpatient$cognitive$rehab$
o$ Inpatient,$6$weeks$(hours/week$
not$reported)$
•$ Comprehensive … $neurorehabilitation$
o$ Inpatient,$37.5$hours/week$for$
6$weeks$
We$identified$no$studies$meeting
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/venous-ulcers-treatment_research-protocol.pdf
September 13, 2012 - standard definition of a chronic venous leg ulcer, which is the presence of an active ulcer
for 6 weeks … Long-term recurrent reflux and ulceration
Timing
• Durations with 4 or more weeks of followup … (KQs 1, 2, & 3)
Intermediate outcomes
Wound healing at 4 weeks
Pain
Quality of wound bed … Wound recurrence at 24 weeks and at 1
year
Quality of life
Mortality
Functional status … Timing and
Setting
• We will include studies with at least 4 weeks of followup
• We will include
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/hemorrhage-postpartum_research-protocol.pdf
June 11, 2014 - 24
hours of birth, or secondary/delayed/late, occurring more than 24 hours post-birth to up to
12 weeks … postpartum following pregnancy >24 weeks’ gestation
• KQ4: Women with stabilized PPH and acute blood … postpartum following pregnancy of >24 weeks’ gestation. … postpartum following pregnancy
>24 weeks’ gestation and include all birth settings (hospital, birth … postpartum
following
pregnancy of >24
weeks’ gestation
Intermediate
outcomes
§ Blood loss
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/phenylketonuria_executive.pdf
February 01, 2012 - In the second model, Phe
and IQ were measured concurrently (within 6 weeks of
each other). … The
study reported that timing of maternal metabolic control,
defined as the number of weeks gestation … half of treated participants (32
to 50 percent) at dosages of 5 to 20 mg/kg/day and for
up to 22 weeks … At a dosage of 20
mg/kg/day over 10 weeks, participants in the treatment
group increased their Phe … The
trials were short, with treatment between 1 and 8 weeks,
and dosages ranged from 250 mg/kg/day
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-table-e5-2022-update_0.xlsx
January 01, 2022 - , Median) Pain Duration, Months Psychiatric Comorbidity % N Interventions Dose Treatment Duration (Weeks … NA
CBD: 202.18 (SD 345.23) 12 weeks (3 months) Short A vs.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/hepatitis-c-treatment-adherence_research-protocol.pdf
September 13, 2011 - The therapy is typically administered for 24
weeks in patients infected with HCV genotype 2 or 3 and … may be extended up to 48 weeks for
patients with HCV genotype 1.5,6 The effects of antiviral therapies … Adults undergoing:
HCV monotherapy
Adults undergoing long-term HCV
maintenance therapy (>52 weeks … Cross-sectional
Case series
Intervention
Duration
Any
Minimum
Followup
KQs 1–3
12 weeks … vs 72
weeks of pegylated interferon and ribavirin.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-208-bipolar-adults-disposition-comments.pdf
August 07, 2018 - Given
that depressive episodes are
typically of longer duration than
mania (i.e. at least two weeks … For acute mania treatment,
outcomes were grouped by 3-4 weeks and then final measurement
(generally … 6 to 12 weeks) if available.” … While
the protocol stated we would
abstract outcomes at the 3 weeks
and final time frame for acute … Outcomes at times
different than 3 weeks are
specifically noted.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/hepatitis-c_disposition-comments.pdf
November 27, 2012 - , in some
patients with early virologic response, compared with
48 weeks for dual therapy. … Executive Summary
(ES-2)
Boceprevir has a duration of therapy of 28 weeks, as
opposed to 24 weeks … period of dual
therapy followed by 24 weeks of triple therapy with
boceprevir. … of dual therapy” should read “…randomized to
24 compared with 28 weeks of dual therapy”. … or 28
additional weeks of therapy.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/progestogens-preterm-birth_research-protocol.pdf
June 01, 2010 - Systematic Review
Background
Preterm birth is the delivery of an infant before the completion of 37 weeks … restrict use of 17-OHP to women with a documented history of a previous
spontaneous birth at less than 37 weeks … Key Questions
Question 1
In pregnant women who are at risk for preterm birth (< 37 weeks estimated … Key Question
Fetal/neonatal outcomes:
• Gestational age at birth, including preterm birth (< 37 weeks … ; cut points such as < 28, <
32, and < 34 weeks; and weeks of gestation among preterm births, as a
-
effectivehealthcare.ahrq.gov/sites/default/files/masks-surveillance-2-appendix-table-a-1.xlsx
April 09, 2020 - Students without specific contact with cases Not reported, other than as part of interventions 6 weeks … Students without specific contact with cases Not reported, other than as part of interventions 6 weeks … HCWs Not reported 4 weeks A. 33.6
B. 31.3
C. 34.2 A. 85.7%
B. 86.8%
C. 83.9%
A. 4.1%
B. 3.1%
C. 4.0% … HCWs HCWs in the cloth mask group asked to wash masks with soap and water every day 4 weeks A: 36
B: … Unspecified infection prevention policies were followed at each study site. 12 weeks A: 43
B: 43 A: 85.0